Mustang Bio, Inc.
MBIO
$1.11
$0.021.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 69.47% | 62.61% | 55.19% | 46.12% | 33.44% |
| Total Depreciation and Amortization | -63.01% | -58.79% | -54.67% | -35.73% | -26.59% |
| Total Amortization of Deferred Charges | -- | -100.00% | -100.00% | -104.21% | -74.89% |
| Total Other Non-Cash Items | 50.36% | -11.50% | -64.62% | -29.30% | -44.03% |
| Change in Net Operating Assets | 78.90% | 275.53% | 42.73% | -526.54% | -173.85% |
| Cash from Operations | 76.94% | 71.02% | 56.14% | 44.45% | 23.96% |
| Capital Expenditure | -- | 76.74% | 97.29% | 95.36% | 97.64% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | 4,624.41% | 4,624.41% | 4,624.41% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | 86.30% | 86.30% | 86.30% |
| Cash from Investing | -- | -100.55% | 539.82% | 463.78% | 299.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | -- | -- |
| Issuance of Common Stock | 168.41% | 3,278.95% | 1,081.58% | 21.99% | -30.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -226.97% | -42,266.67% | -9,275.00% | -394.44% | 83.95% |
| Cash from Financing | 143.19% | 134.24% | 132.29% | -778.80% | -176.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.79% | 92.19% | 87.54% | 11.24% | -105.15% |